ALZ.ST
Alzinova AB
Price:  
1.90 
SEK
Volume:  
231,444.00
Sweden | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ALZ.ST WACC - Weighted Average Cost of Capital

The WACC of Alzinova AB (ALZ.ST) is 6.0%.

The Cost of Equity of Alzinova AB (ALZ.ST) is 6.05%.
The Cost of Debt of Alzinova AB (ALZ.ST) is 5.00%.

Range Selected
Cost of equity 5.30% - 6.80% 6.05%
Tax rate 20.60% - 20.90% 20.75%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.3% - 6.8% 6.0%
WACC

ALZ.ST WACC calculation

Category Low High
Long-term bond rate 2.5% 3.0%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.34 0.38
Additional risk adjustments 1.0% 1.5%
Cost of equity 5.30% 6.80%
Tax rate 20.60% 20.90%
Debt/Equity ratio 0 0
Cost of debt 5.00% 5.00%
After-tax WACC 5.3% 6.8%
Selected WACC 6.0%

ALZ.ST's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for ALZ.ST:

cost_of_equity (6.05%) = risk_free_rate (2.75%) + equity_risk_premium (5.60%) * adjusted_beta (0.34) + risk_adjustments (1.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.